We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
+9.03%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.14B
AUM Growth
-$67M
(-2.1%)
Cap. Flow
-$232M
Cap. Flow
% of AUM
-7.39%
Top 10 Holdings %
Top 10 Hldgs %
17.34%
Holding
430
New
63
Increased
87
Reduced
126
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$36.9M |
| 2 |
Microchip Technology
MCHP
|
+$29.9M |
| 3 |
Costco
COST
|
+$24.9M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$23.6M |
| 5 |
Biogen
BIIB
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$33.1M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$27.6M |
| 3 |
ConocoPhillips
COP
|
+$26.9M |
| 4 |
Devon Energy
DVN
|
+$26.3M |
| 5 |
Walt Disney
DIS
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Industrials | 13.85% |
| 5 | Energy | 13.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
A.O. Smith
AOS
$8.53B
| $5.83M | 0.19% |
132,336
-146,200
| -52% | -$5.9M |
|
152
TotalEnergies
TTE
$193B
| $5.7M | 0.18% |
118,440
+9,110
| +8% | +$436K |
|
153
SLB Ltd
SLB
$72.9B
| $5.66M | 0.18% |
71,591
-51,209
| -42% | -$3.93M |
|
154
Prestige Consumer Healthcare
PBH
$2.47B
| $5.64M | 0.18% |
101,740
-30,680
| -23% | -$1.69M |
|
155
Albany International
AIN
$2.1B
| $5.63M | 0.18% |
+141,044
| New | +$5.57M |
|
|
JCP
156
DELISTED
J.C. Penney Company, Inc.
JCP
| $5.61M | 0.18% |
631,255
-261,595
| -29% | -$2.3M |
|
157
Blackbaud
BLKB
$1.95B
| $5.58M | 0.18% |
82,218
-25,830
| -24% | -$1.63M |
|
|
WAGE
158
DELISTED
WageWorks, Inc.
WAGE
| $5.57M | 0.18% |
+93,138
| New | +$5.15M |
|
159
Intuitive Surgical
ISRG
$127B
| $5.52M | 0.18% |
75,150
| – | – |
|
|
ULTI
160
DELISTED
Ultimate Software Group Inc
ULTI
| $5.51M | 0.18% |
26,206
-4,230
| -14% | -$839K |
|
161
Trimble
TRMB
$13.6B
| $5.5M | 0.18% |
225,605
+3,270
| +1% | +$81.8K |
|
162
FIVE9
FIVN
$2.08B
| $5.49M | 0.18% |
+461,084
| New | +$4.68M |
|
|
WCN
163
Waste Connections
WCN
$43.7B
| $5.4M | 0.17% |
112,365
-17,700
| -14% | -$805K |
|
|
CTRA
164
DELISTED
Coterra Energy
CTRA
| $5.32M | 0.17% |
206,770
+154,800
| +298% | +$3.71M |
|
165
Global Payments
GPN
$24.2B
| $5.21M | 0.17% |
72,952
-11,380
| -13% | -$840K |
|
166
LendingTree
TREE
$545M
| $5.2M | 0.17% |
+58,825
| New | +$4.98M |
|
|
167
ConocoPhillips
COP
$144B
| $5.19M | 0.17% |
119,060
-611,095
| -84% | -$26.9M |
|
168
Spectrum Brands
SPB
$2.03B
| $5.09M | 0.16% |
42,670
-6,730
| -14% | -$773K |
|
|
NVRO
169
DELISTED
NEVRO CORP.
NVRO
| $5.08M | 0.16% |
68,875
+3,460
| +5% | +$235K |
|
170
LKQ Corp
LKQ
$6.71B
| $4.94M | 0.16% |
155,759
-24,500
| -14% | -$796K |
|
171
Aramark
ARMK
$15.1B
| $4.79M | 0.15% |
198,563
-31,066
| -14% | -$748K |
|
|
SEE
172
DELISTED
Sealed Air
SEE
| $4.75M | 0.15% |
103,273
-13,990
| -12% | -$669K |
|
|
SPNC
173
DELISTED
Spectranetics Corp
SPNC
| $4.71M | 0.15% |
+251,445
| New | +$4.43M |
|
174
Equifax
EFX
$22.1B
| $4.65M | 0.15% |
36,237
-15,545
| -30% | -$1.88M |
|
|
EQM
175
DELISTED
EQM Midstream Partners, LP
EQM
| $4.65M | 0.15% |
57,930
-36,340
| -39% | -$2.74M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2016 Portfolio in Review
As of Q2 2016, Castleark Management held 430 positions worth $3.14B, down 2.1% from $3.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Castleark Management withdrew a net $232M in Q2 2016, closing 57 positions and reducing 126 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $16M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Biogen worth $16.1M.
- Castleark Management's largest Q2 2016 buy was Biogen: 66,490 shares worth $16.1M.
- Castleark Management added most to Medtronic in Q2 2016, an estimated $36.9M increase.
- Castleark Management's biggest Q2 2016 reduction was Nike, cutting an estimated $33.1M.
- Castleark Management fully exited Nuance Communications, Inc. in Q2 2016, selling an estimated $16M.
- Castleark Management's ten largest holdings make up 17% of its $3.14B portfolio in Q2 2016.
- Castleark Management opened 63 new positions and closed 57 in Q2 2016.
- Castleark Management's portfolio value fell 2.1% quarter-over-quarter to $3.14B.
Based on Castleark Management's 13F filing for Q2 2016, filed 10 Aug 2016.